SURMOUNT-4 was built to answer the stopping question, and it did
The regain trajectories, arm by arm, with the estimands named.
TheCompound Journal
Reporting on incretins, compounding & the peptide supply chain
Drug shortage declarations, the compounding they permitted, and their resolution.
The regain trajectories, arm by arm, with the estimands named.
What the labels permit, what clinicians do, and the size of the gap between them.
The document is four pages. Three of them are about dates.
The document is four pages. Three of them are about dates.
The document is four pages. Three of them are about dates.
The document is four pages. Three of them are about dates.
Dose reduction is not withdrawal, and the trials that tested withdrawal cannot be read as testing it.
The document is four pages. Three of them are about dates.
The document is four pages. Three of them are about dates.
The document is four pages. Three of them are about dates.
Real-world persistence figures, with their definitions stated, because the definitions are doing most of the work.
The document is four pages. Three of them are about dates.
The trials studied planned withdrawal. Almost nobody stops that way.
The document is four pages. Three of them are about dates.
A supply interruption is a discontinuation with no notice, no taper and no plan. That is a distinct clinical situation.
The document is four pages. Three of them are about dates.
The document is four pages. Three of them are about dates.
The evidence on stopping is better than the evidence on almost anything else in this field, because somebody deliberately randomised it.
What the labels permit, what clinicians do, and the size of the gap between them.
The document is four pages. Three of them are about dates.